Yale Cancer Center

This is your central portal for breaking news, the latest research and important updates from Yale Cancer Center. Bookmark this page and check back often for updates.


In the Journals

Study challenges ‘default use of hypomethylating agents’ in high-risk myelodysplastic syndrome

November 15, 2019
Older patients with myelodysplastic syndrome appeared more likely to receive persistent treatment with hypomethylating agents under the care of more…

GO2 Foundation for Lung Cancer presents awards

November 12, 2019
GO2 Foundation for Lung Cancer presented several awards at its 14th annual Simply the Best Dinner and Gala. Roy S. Herbst, MD, PhD, received…

Hematologists, oncologists elected to National Academy of Medicine

October 30, 2019
The National Academy of Medicine announced the election of 90 regular members and 10 international members. Election to the academy —…

Studies show oncologists can adapt quickly to new evidence

October 28, 2019
Oncologists acted promptly in response to an FDA restriction last year on the label indication for two immunotherapies, effectively reducing their…
In the JournalsPerspective

Power morcellation technique increases mortality risk for women with occult uterine sarcoma

October 11, 2019
Uncontained power morcellation appeared associated with increased risk for mortality among women with occult uterine sarcoma, according to study…
Meeting NewsPerspective

Radiation improves outcomes with pembrolizumab for metastatic lung cancer

September 17, 2019
The addition of stereotactic body radiotherapy after progression on pembrolizumab prolonged PFS among patients with metastatic non-small cell lung…
Meeting News

Nivolumab confers fivefold OS improvement over chemotherapy in advanced NSCLC

September 10, 2019
BARCELONA — Nivolumab led to a fivefold improvement in OS at 5 years compared with docetaxel among

International Association for the Study of Lung Cancer announces president-elect, board members

August 31, 2019
Heather A. Wakelee, MD, has been chosen president-elect of International Association for the Study of Lung Cancer. Wakelee, professor of…
Meeting NewsPerspective

Enfortumab vedotin induces responses in advanced urothelial cancer

June 11, 2019
CHICAGO — The investigational therapy enfortumab vedotin demonstrated an objective response rate of 44% among a cohort of patients with locally…
Meeting News

Conquer Cancer Foundation presents Merit Awards at ASCO

June 6, 2019
CHICAGO — The Conquer Cancer Foundation of ASCO presented ASCO Annual Meeting Merit Awards to more than 100 oncology professionals. The awards…
Meeting NewsPerspective

Medicaid expansion reduces racial disparities in access to timely cancer care

June 4, 2019
CHICAGO — States that expanded Medicaid under the Affordable Care Act appeared to eliminate disparities in timely treatment for black patients…
Meeting NewsPerspective

Pembrolizumab may provide alternative to chemotherapy for certain gastric, gastroesophageal junction cancers

June 1, 2019
CHICAGO — First-line pembrolizumab appeared noninferior to chemotherapy for OS among patients with PD-L1-positive, HER2-negative advanced
Advanced Practice

APP-driven oncology urgent care can improve patient satisfaction, quality of life

HemOnc Today, May 25, 2019
Vanna M. Dest, MSN, APRN-BC, AOCN
Oncology care has shifted to a predominantly ambulatory setting, which has increased the volume of urgent same-day visits for disease and…
In the JournalsPerspective

Top-ranked cancer hospitals outperform affiliates in surgical safety, mortality risk

May 7, 2019
Patients who undergo complex cancer surgery at hospitals affiliated with top-ranked cancer centers have a significantly higher risk for mortality…
Meeting NewsPerspective

Osimertinib plus intermittent selumetinib shows preliminary activity in EGFR-mutated lung cancer

April 2, 2019
ATLANTA — Osimertinib plus intermittent selumetinib demonstrated preliminary antitumor activity and acceptable toxicity in patients with…
In the Journals

Phlebotomy and hydroxyurea improve OS, reduce thrombosis risk in polycythemia vera

January 2, 2019
Therapeutic phlebotomy and hydroxyurea improved OS and reduced risk for thrombosis among older adults with polycythemia vera at high risk for…
Meeting News

Pembrolizumab confers sustained OS benefit in PD-L1-expressing non-small cell lung cancer

December 18, 2018
Patients with previously treated, PD-L1-expressing advanced non-small cell lung cancer experienced long-term OS benefits with pembrolizumab compared…
Meeting News

Racial disparities seen in supportive care use among patients with multiple myeloma

December 11, 2018
SAN DIEGO — Elderly adults with multiple myeloma in the U.S. did not fully utilize available supportive care measures aimed at bone health and…
Cover Story

#MeToo movement in medicine: ‘Community of allies’ required to end culture of sexual harassment

HemOnc Today, December 10, 2018
The statistics are staggering. Up to 50% of female medical students report experiencing sexual harassment from faculty or staff, according to a…

Thermal ablation effective in early-stage lung cancer

November 14, 2018
Thermal ablation conferred OS rates comparable to those of stereotactic radiation therapy among patients with inoperable, stage I non-small cell lung…